139473-80-6

Basic information

• Product Name: Ethanone, 2-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)-
• CAS NO: 139473-80-6
• Molecular Formula: C11H12O5
• Molecular Weight: 224.213
• Mol File: 139473-80-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Ethanone, 2-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 2-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)-(139473-80-6)
• EPA Substance Registry System: Ethanone, 2-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)-(139473-80-6)

Safety Data

• Hazardous Substances Data: 139473-80-6(Hazardous Substances Data)

Upstream product

• 74162-07-5 4-(2-diazoacetyl)-2-methoxyphenyl acetate 
• 6344-28-1 2-chloro-1-(4-hydroxy-3-methoxyphenyl)ethan-1-one 
• 91-16-7 1,2-dimethoxybenzene 
• 50893-83-9 4-acetoxy-β-bromo-3-methoxyacetophenone 
• 127-08-2 potassium acetate 
• 19767-93-2 α,4-diacetoxy-3-methoxyacetophenone 
• 18256-48-9 2,4'-dihydroxy-3'-methoxyacetophenone 

Relevant articles and documents

Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents

A method of treating cardiac dysfunction, the effects of histamine, and gastric secretion excesses with aryl(alkyl and alkylene)-N-[(phenoxy and phenythio)alkyl]aminoheterocyclics corresponding to the formula: STR1 wherein Ar is phenyl or substituted phenyl; R is phenyl, substituted phenyl, pyridinyl or cycloalkyl; A is hydrogen, hydroxy, cyano, amido and amino; Q is --CH2 --, --CH--, or --CHOH--; d and n are zero or one and the dotted lines form double bonds consistent with the valence of carbon; p is zero, one or two; m is one to six inclusive; B is oxygen, nitrogen, sulfur, sulfinyl or sulfonyl; z is zero or one; l is zero or one; W is hydrogen, loweralkyl, halo, nitro, loweralkoxy or hydroxy; X is hydrogen, loweralkyl, halogen, loweralkoxy or hydroxy; Y is --CH(OH)CH2 OH, --CH(OH)C(O)OH, --C(O)C(O)OH, --C(O)CH2 OH,--C(O)C(O)OCH3, --C(O)C(O)OC2 H5, --CH2 C(O)OC2 H5, --CH(OH)C(O)OCH3, --CH(OH)C(O)OC2 H5 or --C(O)CH2 OC(O)CH3 ; and the pharmaceutically acceptable salts thereof; in addition to the above methods of treatment, compounds wherein (B)z is oxygen are useful in a method of treating Gell and Coombs type 1 allergic responses in mammals.